|
Erasca Common
(ERAS)
|
16.3 |
$197M |
|
12M |
16.18 |
|
Praxis Precision Medicines Common
(PRAX)
|
9.1 |
$109M |
|
339k |
322.19 |
|
Terns Pharmaceuticals Common
(TERN)
|
5.8 |
$70M |
|
1.3M |
52.72 |
|
Trevi Therapeutics Common
(TRVI)
|
5.1 |
$61M |
|
5.1M |
11.93 |
|
DBV Technologies SA Sponsored Ads
(DBVT)
|
4.6 |
$56M |
|
2.7M |
20.89 |
|
Compass Therapeutics Common
(CMPX)
|
4.2 |
$51M |
|
9.5M |
5.29 |
|
Tango Therapeutics Common
(TNGX)
|
3.7 |
$45M |
|
2.2M |
20.92 |
|
SAB Biotherapeutics Common
(SABS)
|
3.6 |
$44M |
|
11M |
3.83 |
|
Corvus Pharmaceuticals Holdings Common
(CRVS)
|
3.4 |
$41M |
|
2.8M |
14.63 |
|
Bright Minds Biosciences Common
(DRUG)
|
3.4 |
$41M |
|
557k |
72.97 |
|
Sinovac Biotech SHS
|
3.2 |
$38M |
|
5.9M |
6.47 |
|
Dianthus Therapeutics Common
(DNTH)
|
2.5 |
$30M |
|
354k |
83.92 |
|
Dyne Therapeutics Common
(DYN)
|
2.3 |
$28M |
|
1.6M |
18.13 |
|
Abivax SA - Sponsored Ads
(ABVX)
|
2.2 |
$27M |
|
240k |
111.35 |
|
Minerva Neurosciences Common
(NERV)
|
2.2 |
$26M |
|
4.3M |
6.03 |
|
Aclaris Therapeutics Common
(ACRS)
|
2.1 |
$25M |
|
6.7M |
3.75 |
|
Oric Pharmaceuticals Common
(ORIC)
|
1.9 |
$23M |
|
1.8M |
12.67 |
|
Alto Neuroscience Common
(ANRO)
|
1.9 |
$23M |
|
1.0M |
22.48 |
|
Sensei Biotherapeutics Common
(SNSE)
|
1.9 |
$23M |
|
722k |
31.52 |
|
Arrivent BioPharma Common
(AVBP)
|
1.7 |
$20M |
|
886k |
23.07 |
|
LB Pharmaceuticals Common
(LBRX)
|
1.6 |
$20M |
|
800k |
24.66 |
|
Veradermics Common
|
1.6 |
$19M |
|
300k |
63.15 |
|
CAMP4 Therapeutics Common
(CAMP)
|
1.6 |
$19M |
|
4.2M |
4.41 |
|
Moonlake Immunotherapeutics Common
(MLTX)
|
1.5 |
$19M |
|
1.0M |
18.64 |
|
Design Therapeutics Common
(DSGN)
|
1.4 |
$17M |
|
1.6M |
10.64 |
|
Cogent Biosciences Common
(COGT)
|
1.4 |
$16M |
|
422k |
38.49 |
|
Geron Corp Common
(GERN)
|
1.1 |
$13M |
|
8.7M |
1.49 |
|
Unicycive Therapeutics Common
(UNCY)
|
1.0 |
$12M |
|
1.8M |
6.58 |
|
AN2 Therapeutics Common
(ANTX)
|
0.9 |
$11M |
|
3.2M |
3.42 |
|
Olema Pharmaceuticals Common
(OLMA)
|
0.8 |
$10M |
|
672k |
14.91 |
|
Soleno Therapeutics Common
(SLNO)
|
0.8 |
$9.9M |
|
295k |
33.48 |
|
Eupraxia Pharmaceuticals Common
(EPRX)
|
0.8 |
$9.8M |
|
1.4M |
7.24 |
|
Onkure Therapeutics Common
(OKUR)
|
0.7 |
$8.0M |
|
1.9M |
4.14 |
|
Surrozen Common
(SRZN)
|
0.6 |
$7.6M |
|
260k |
29.13 |
|
ALX Oncology Holdings Common
(ALXO)
|
0.5 |
$6.4M |
|
3.2M |
2.00 |
|
Monopar Therapeutics Common
(MNPR)
|
0.4 |
$5.0M |
|
91k |
54.79 |
|
Satellos Bioscience Common
|
0.4 |
$4.6M |
|
814k |
5.63 |
|
Pepgen Common
(PEPG)
|
0.3 |
$4.1M |
|
2.3M |
1.77 |
|
Sera Prognostics Common
(SERA)
|
0.3 |
$3.4M |
|
1.7M |
2.03 |
|
Tenax Therapeutics Common
(TENX)
|
0.3 |
$3.3M |
|
208k |
15.99 |
|
Viridian Therapeutics Common
(VRDN)
|
0.3 |
$3.3M |
|
166k |
19.56 |
|
Instil Bio Common
(TIL)
|
0.2 |
$2.4M |
|
293k |
8.24 |
|
Pasithea Therapeutics Corp Common
(KTTA)
|
0.1 |
$1.6M |
|
2.1M |
0.74 |
|
Compass Pathway Sponsored Ads
(CMPS)
|
0.1 |
$1.1M |
|
200k |
5.53 |
|
Bolt Therapeutics Common
(BOLT)
|
0.0 |
$293k |
|
72k |
4.04 |
|
Precision Biosciences Common
(DTIL)
|
0.0 |
$26k |
|
4.7k |
5.50 |